The epidemiology of invasive pneumococcal disease in alaska, 1986-1990 ethnic differences and opportunities for prevention

Journal of Infectious Diseases

Volumn 170, Issue 2, 1994, Pages 368-376

  Davidson, Michael ^a   Parkinson, Alan J ^a,b   Bulkow, Lisa R ^a   Fitzgerald, Mary Anne ^a   Peters, Helen ^a   Parks, Debra J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE PREDISPOSITION; ETHNIC GROUP; HUMAN; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; STREPTOCOCCUS INFECTION; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALASKA; BACTEREMIA; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INFANT; INUITS; MALE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RECURRENCE; SEROTYPING; SEX FACTORS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0028238927     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.2.368     Document Type: Article

References (52)

1. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986;5:247-52.
2. Barker J, Gratten M, Riley I, et al. Pneumonia in children in the eastern highlands of Papua New Guinea: A bactériologie study of patients selected by standard clinical criteria. J Infect Dis 1989;159:348-52.
3. Denny FW, Loda FA. Acute respiratory infections are the leading cause of death in children in developing countries. Am J Trop Med Hyg 1986;35:1-2.
4. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60:759-76.
5. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumo coccal bacteremia in Charleston County, South Carolina: A decade later. Arch Intern Med 1990;150:1401-5.
6. Kramer MR, Rudensky B, Hadas-Halperin I, Hadas-Halperin I, Isac-sohn M, Melzer E. Pneumococcal bacteremia-no change in mortality in 30 years: Analysis of 104 cases and review of the literature. Israel J Med Sei 1987;23:174-9.
7. Hook EW, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983;249:1055-7.
8. Bruyn GAW, van der Meer JWM, Hermans J, et al. Pneumococcal bacteremia in adults over a 10-year period at University Hospital, Leiden. Rev Infect Dis 1988;10:446-50.
9. Jette LP, Lamothe F, Pneumococcus Study Group. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: Serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 1989;27:1-5.
10. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis. Rev Infect Dis 1985;7:133-42.
11. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Pub Health 1992;82:1513-6.
12. Davidson M, Schraer CD, Parkinson AJ, et al. Invasive pneumococcal disease in an Alaska Native population, 1980 through 1986. JAMA 1989;261:715-8.
13. Gilsdorf JR. Bacterial meningitis in southwestern Alaska. Am M Epidemiol 1977;106:388-91.
14. Gilsdorf JR. Leading health problems, fiscal year 1990. Anchorage: Alaska Area Native Health Service, 1992.
15. Fattom A, Lue C, Szu SC, et al. Serum antibody response in adult volunteers elicited by infection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infect Immun 1990;58:2309-12.
16. Cortese MM, Wolff M, Almeido-Hill J, Reid R, Ketcham J, Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1992; 152:2277-82.
17. Felice GA, Darby CP, Fraser DW. Pneumococcal bacteremia in Charleston County, South Carolina. Am J Epidemiol 1980; 112:828-35.
18. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D, Pneumococcus Study Group. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis 1987;156:732-5.
19. Broome CV, Facklam RR. Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev Infect Dis 1981;3:277-80.
20. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986:171.
21. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J Infect Dis 1994;170:461-4.
22. Finley JC, Davidson M, Parkinson AJ, Sullivan RW. Pneumococcal endocarditis in Alaska: A population-based experience, 1978-90. Arch Intern Med 1992;152:1641-5.
23. Mufson MA, Oley G, Hughey D. Pneumococcal infections in a medium-sized community in the United States. JAMA 1982;248: 1486-9.
24. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992;268:3323-7.
25. Israeli Pediatric Bacteremia and Meningitis Group. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA 1992;268:3328-32.
26. Schlech WF, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV. Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study. JAMA 1985; 253:1749-54.
27. Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis 1981;3(suppl): 1-17.
28. Davidson M, Tempest B, Palmer DL. Bactériologie diagnosis of acute pneumonia: Comparison of sputum, transtracheal aspirates, and lung aspirates. JAMA 1976;235:158-63.
29. Gray BM, Converse GM, Dillon HC Jr. Serotypes of Streptococcus pneumoniae causing disease. J Infect Dis 1979;140:979-83.
30. Garcia-Leoni ME, Moreno S, Rodeno P, Cercenado E, Vicente T, Bouza E. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992;152:1808-12.
31. Schuchat A, Broome CV, Hightower A, Costa SJ, Parkin W. Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. JAMA 1991; 265:3275-9.
32. Redd SC, Rutherford GW, Sande MA, Lifson AR, Facklam RR, Spika JS. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990;162:1012-7.
33. Alaska Bureau of Vital Statistics. 1988-1989 annual report. Juneau: State of Alaska, Department of Health & Social Services, 1992.
34. Peterson GM, Silimperi DR, Scott EM, Hall DB, Rotter JI, Ward JI Uridine monophosphate kinase 3: A genetic marker for susceptibility to Haemophilus influenzae type b disease. Lancet 1985;2:417-8.
35. Peterson GM, Silimperi DR, Rotter JI, et al. Genetic factors in Haemo philus influenzae type b disease susceptibility and antibody acquisition. J Pediatr 1987;110:228-33.
36. Munoz R, Musser JM, Crain M, et al. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: Characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 1992; 15:112-8.
37. Ussery XT, Gessner B, Tien P, et al. Spread of a drug-resistant pneumococcal strain among Alaskan children. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology. 1993.
38. Lanier AP. Bulkow LR, Novotny TE, Giovino GA, Davis RM. Tobacco use and its consequences in northern populations. Arctic Med Res 1990;49(suppl 2): 17-22.
39. Davidson M, Schnitzer PG, Bulkow LR, et al. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 1994;169:792-800.
40. Etzel RA, Jones DB, Schlife CM, Lyke JR, Spierto FW, Middaugh JP Passive smoking and tobacco chewing among Alaskan children: Measuring saliva cotinine. J Smoking Related Dis 1992;3:161-5.
41. Raman AS, Swinburne AJ, Fedullo AJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest 1983;83:23-7.
42. Chen Y. Li W. Yu S. Influence of passive smoking on admissions for respiratory illness in early childhood. Br Med J 1986;293:303-6.
43. Siber G, Thompson C, Reid GR, et al. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J Infect Dis 1992; 165(suppl 1):S129-33.
44. Douglas R, Paton J, Duncan S, Hansman D. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
45. Douglas R, Miles H. Vaccination against Streptococcus pneumoniae inchildhood: Lack of demonstrable benefit in young Australian children. J Infect Dis 1984;149:861-9.
46. Pomat WS, Smith TA, Sanders RC, et al. Levels of anti-pneumococcal antibodies in young children in Papua New Guinea. Epidemiol Infect 1993;111:109-19.
47. Witt CS, Pomat W, Lehmann D, Alpers MP. Antibodies to pneumo coccal polysaccharides in pneumonia and response to pneumococcal vaccination in young children in Papua New Guinea. Clin Exp Immunol 1991;83:219-24.
48. Riley ID, Lehmann D, Alpers MP, Marshall TF de C, Gratten J, Smith D. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children. Lancet 1986;2:877-81.
49. Lehmann D, Marshall TF de C, Riley ID, Alpers MP. Effect of pneumo coccal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinea children. Ann Trop Paediatr 1991;11:247-57.
50. Siber GR, Santosham M, Reid GF, Thompson C, Almeido-Hill J, Mor-ell A. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG 1 concentrations in Apache children. N Engl J Med 1990;323:387-92.
51. Howie VM, Ploussard J, Sloyer JL, Hill JC. Use of pneumococcal poly saccharide vaccine in preventing otitis media in infants: Different results between racial groups. Pediatrics 1984;73:79-81.
52. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee (ACIP). Update: Pneumococcal polysaccharide vaccine usage—United States. MMWR 1984;33:273-81.